These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34747048)

  • 1. A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy.
    Rafique M; Solberg OG; Gullestad L; Bendz B; Holm NR; Neghabat O; Dijkstra J; Nytrøen K; Rolid K; Lunde K
    Clin Transplant; 2022 Jan; 36(1):e14488. PubMed ID: 34747048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity interval training and health-related quality of life in de novo heart transplant recipients - results from a randomized controlled trial.
    Rolid K; Andreassen AK; Yardley M; Gude E; Bjørkelund E; Authen AR; Grov I; Pettersen KI; Dall CH; Karason K; Broch K; Gullestad L; Nytrøen K
    Health Qual Life Outcomes; 2020 Aug; 18(1):283. PubMed ID: 32807179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative 3D Analysis of Coronary Wall Morphology in Heart Transplant Patients: OCT-Assessed Cardiac Allograft Vasculopathy Progression.
    Chen Z; Pazdernik M; Zhang H; Wahle A; Guo Z; Bedanova H; Kautzner J; Melenovsky V; Kovarnik T; Sonka M
    Med Image Anal; 2018 Dec; 50():95-105. PubMed ID: 30253306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high-intensity interval training on progression of cardiac allograft vasculopathy.
    Nytrøen K; Rustad LA; Erikstad I; Aukrust P; Ueland T; Lekva T; Gude E; Wilhelmsen N; Hervold A; Aakhus S; Gullestad L; Arora S
    J Heart Lung Transplant; 2013 Nov; 32(11):1073-80. PubMed ID: 23906899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and rationale of the HITTS randomized controlled trial: Effect of High-intensity Interval Training in de novo Heart Transplant Recipients in Scandinavia.
    Nytrøen K; Yardley M; Rolid K; Bjørkelund E; Karason K; Wigh JP; Dall CH; Arora S; Aakhus S; Lunde K; Solberg OG; Gustafsson F; Prescott EI; Gullestad L
    Am Heart J; 2016 Feb; 172():96-105. PubMed ID: 26856221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of high-intensity training vs moderate intensity training in heart transplant recipients: A 3-year follow-up study of the randomized-controlled HITTS study.
    Rolid K; Andreassen AK; Yardley M; Gude E; Bjørkelund E; Authen AR; Grov I; Broch K; Gullestad L; Nytrøen K
    Am J Transplant; 2020 Dec; 20(12):3538-3549. PubMed ID: 32484261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients in Scandinavia.
    Nytrøen K; Rolid K; Andreassen AK; Yardley M; Gude E; Dahle DO; Bjørkelund E; Relbo Authen A; Grov I; Philip Wigh J; Have Dall C; Gustafsson F; Karason K; Gullestad L
    Circulation; 2019 May; 139(19):2198-2211. PubMed ID: 30773030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation.
    Park KH; Sun T; Liu Z; Yang SW; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    J Heart Lung Transplant; 2017 Feb; 36(2):185-192. PubMed ID: 27461884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of early changes in the coronary artery microstructure after heart transplantation: A prospective optical coherence tomography study.
    Clemmensen TS; Holm NR; Eiskjær H; Jakobsen L; Berg K; Neghabat O; Løgstrup BB; Christiansen EH; Dijkstra J; Terkelsen CJ; Maeng M; Poulsen SH
    J Heart Lung Transplant; 2018 Apr; 37(4):486-495. PubMed ID: 29128426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate and early progression of cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.
    Pazdernik M; Wichterle D; Chen Z; Bedanova H; Kautzner J; Melenovsky V; Karmazin V; Malek I; Stiavnicky P; Tomasek A; Ozabalova E; Krejci J; Wahle A; Zhang H; Kovarnik T; Sonka M
    Clin Transplant; 2020 Feb; 34(2):e13773. PubMed ID: 31859379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical Coherence Tomography for the Early Detection of Coronary Vascular Changes in Children and Adolescents After Cardiac Transplantation: Findings From the International Pediatric OCT Registry.
    McGovern E; Hosking MCK; Balbacid E; Voss C; Berger F; Schubert S; Harris KC
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2492-2501. PubMed ID: 30031706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of cardiac allograft vasculopathy using highly automated 3-dimensional optical coherence tomography analysis.
    Pazdernik M; Chen Z; Bedanova H; Kautzner J; Melenovsky V; Karmazin V; Malek I; Tomasek A; Ozabalova E; Krejci J; Franekova J; Wahle A; Zhang H; Kovarnik T; Sonka M
    J Heart Lung Transplant; 2018 Aug; 37(8):992-1000. PubMed ID: 29706574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.
    Imamura T; Kinugawa K; Murasawa T; Kagami Y; Endo M; Muraoka H; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Komuro I; Ono M
    Int Heart J; 2014; 55(2):178-80. PubMed ID: 24632967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography.
    Cassar A; Matsuo Y; Herrmann J; Li J; Lennon RJ; Gulati R; Lerman LO; Kushwaha SS; Lerman A
    Eur Heart J; 2013 Sep; 34(33):2610-7. PubMed ID: 23801824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of high-intensity interval training in heart transplant recipients: A 5-year follow-up study of a randomized controlled trial.
    Yardley M; Gullestad L; Bendz B; Bjørkelund E; Rolid K; Arora S; Nytrøen K
    Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27865004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of physical capacity and the effects of exercise in heart transplant recipients.
    Yardley M; Gullestad L; Nytrøen K
    World J Transplant; 2018 Feb; 8(1):1-12. PubMed ID: 29507857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial.
    Broch K; Gude E; Karason K; Dellgren G; Rådegran G; Gjesdal G; Gustafsson F; Eiskjaer H; Lommi J; Pentikäinen M; Lemström KB; Andreassen AK; Gullestad L
    Clin Transplant; 2020 Sep; 34(9):e13984. PubMed ID: 32445429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high-intensity interval training on cardiac remodelling, function and coronary microcirculation in de novo heart transplant patients: a substudy of the HITTS randomised controlled trial.
    Rafique M; Solberg OG; Gullestad L; Bendz B; Murbræch K; Nytrøen K; Rolid K; Lunde K
    BMJ Open Sport Exerc Med; 2023; 9(3):e001331. PubMed ID: 37440977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.